Prof. Janet Mifsud

Prof. Janet Mifsud

Prof. Janet Mifsud



Room 117
Biomedical Building Extn
University of Malta
  +356 2340 2845
Prof Janet Mifsud obtained her PhD in UK in 1995 on the pharmacology of chiral antiepileptic drugs. Her research activities in epilepsy are undertaken with colleagues in Mater Dei Hospital, University College London and numerous other international epilepsy centres. She has published extensively and has been appointed on the organising and scientific committees of several international epilepsy conferences. Prof Mifsud was Secretary General for the European Epilepsy Academy and also Vice-President for the International Bureau for Epilepsy; and she is presently member, Joint Task Force, European Epilepsy Research and Advocacy. She is an advisor, Caritas Malta Epilepsy Association. She was officially awarded the title of Epilepsy Ambassador by the International League Against epilepsy and International Bureau of Epilepsy in 2019.

Prof Mifsud co-ordinates pharmacology study units offered at the University of Malta for Faculties of Medicine and Surgery; Health Sciences; Science; Education; and Dental Surgery. She also co-ordinates a Masters in Pharmacotoxicology and the preparation of final year MD students for the UK Prescribing Skills Assessment. She was elected Fellow of the British Pharmacological Society in 2017 and in 2019 was appointed Review Science Editor for the British Journal of Clinical Pharmacology.

She is involved in several EU and internationally funded projects in FP7. H2020, Ersamus+ and IMI. She has also been invited to act as external expert evaluator for scientific projects for several international and European wide panels. Prof Mifsud is national expert on the Pharmacokinetics Working Group (PKWP) in European Medicines Agency.

On a national level, she was the first Commissioner, National Commission for the Promotion of Equality (NCPE) and was for several years a member of the Public Service Commission, a member of the Centre for Freedom from Addiction, President's Foundation for the Wellbeing of Society; and a member of the Fund for Voluntary Organisations, Malta Community Chest Fund. She is presently Board Member, New Hope Services for Drug Rehabilitation, Caritas Malta.
  • Pharmacokinetics, Pharmacometrics and Pharmacogenetics
  • Pharmacology of drugs used in chronic neurological disorders specifically anti-epileptic drugs
  • Pharmacotoxicology
  • Abuse and misuse of over the counter drugs and Drug Doping in sports
  • Stigma and inclusion in epilepsy
  • Ethical issues in health care and pharmacology
  • Gender and science
  • CHE1012 - Principles of Chemistry and Biochemistry related to Care
  • CMT5002 - Audiological Management: Adults
  • CPH1710 - Pharmacological Principles in Dentistry
  • CPH1800 - Basic Principles of General Pharmacology in Food Science
  • CPH1901 - Drug Receptor Theory
  • CPH1902 - Overview of Drug Classes and Function
  • CPH1903 - Drug Discovery, Development, Regulatory Aspects, Pharmacovigilance
  • CPH1904 - Drug Formulations and Routes of Administration
  • CPH1905 - Pharmacokinetics and Pharmacodynamics 1
  • CPH1906 - Research Tools and Study Design in Molecular Pharmacology
  • CPH1907 - Pharmacogenetics and Pharmacogenomics
  • CPH1908 - Principles of Pharmacotherapeutics
  • CPH1909 - Pharmacology Seminars 1
  • CPH2011 - Drugs used in Disorders of the Nervous and Cardiovascular Systems
  • CPH2110 - Introduction to Molecular and Clinical Pharmacology
  • CPH2301 - Introduction to Pharmacology for Applied Biomedical Science Students
  • CPH2402 - Pharmacology for Allied Health Care Professionals
  • CPH2404 - Pharmacology for Midwifery Students
  • CPH2901 - Approaches to Analysis of Drugs and Metabolites
  • CPH2902 - Pharmacokinetics and Pharmacodynamics 2
  • CPH2903 - Antibiotics, Antifungals, Antivirals and Antihelminthics
  • CPH2904 - Biological Drugs, Vaccines, Gene Therapy and Pharmacological Biotechnology
  • CPH2905 - Drugs used in Pain, Inflammation, Fever, Rheumatology and Nephrology
  • CPH2906 - Drugs used in Ophthalmology, Blood Disorders, Bone Disorders, Vitamins and the use of Hyperbaric Oxygen
  • CPH2907 - Societal impact of Pharmacology and Rational Drug Use
  • CPH2908 - Research Approaches in Clinical Pharmacology and Medicine Use
  • CPH2910 - Pharmacology Seminars 2
  • CPH2911 - Pharmacology Placements
  • CPH3010 - Drugs used in Asthma, COPD and Epilepsy: Applications of Pharmacokinetics
  • CPH3601 - Introduction to Pharmacology for Chemistry Students
  • CPH3700 - Theory and Applications of Molecular Pharmacology
  • CPH3901 - Pharmacotoxicology, Toxicogenomics, Drugs of Abuse
  • CPH3903 - Accessing, Evaluating and Reporting Scientific Data in Pharmacology and Toxicology
  • CPH3904 - Pharmacology Seminars 3
  • CPH3905 - In Vitro and in Vivo Models and Translational Research in Pharmacology and Toxicology
  • CPH3910 - Research Project
  • CPH4120 - Applied Molecular and Clinical Pharmacology
  • CPH4500 - Introduction to Pharmacology for Biology and Chemistry Students
  • CPH4600 - Pharmacology for Podiatry Students
  • CPH5401 - Fundamentals of Pharmacotoxicology: Principles, Classification and Toxicokinetics
  • CPH5402 - Mechanisms of Drug Toxicity: Molecular, Cellular and Pathological
  • CPH5403 - Clinical Toxicology and Management of Poisoning of Commonly Used Pharmaceuticals 1
  • GDS5007 - Gender and Social Justice
  • MDS1036 - Renal System
  • MDS1037 - Organisation of the Body
  • MDS2009 - Pharmacology
  • MDS2031 - Gastrointestinal System
  • MDS3011 - Clinical Pharmacology and Therapeutics 1
  • MDS4013 - Neurology and Ophthalmology
  • MDS4033 - Essential Core Competences
  • PSY3644 - Child and Adolescent Psychopathology
  • RAD3330 - Pharmacology and Radiopharmacy for Radiographers
Research work in progress

- Pharmacokinetics and pharmacogenetics of drugs used in chronic neurological disorders
- OTC drug use and misuse and drug doping in sports
- Neurotoxicology and poisoning
- Stigma and educational inclusion in epilepsy

Involvement in projects and ongoing collaborations

- Member of the Scientific Advisory Board, IMI project NeuroDeRixk Neurotoxicity DeRisking in
Preclinical Drug Discovery IMI-JU 821528 2019-2023
- Consortium Parter, H2020 GENDER ACTION GENDer equality in the ERA Community To Innovate
policy implementatiON. Coordination and Support Action SwafS-19-216 2017-2021
- Chair, Dissemination board and Ethics Board FP7 DESIRE Development and Epilepsy Strategies
for innovative research to improve Diagnosis, Prevention and Treatment in children with
Difficult to Treat Epilepsy (Health-F2-602531-2013)(2013-2018)
- Workpackage leader Parter, Erasmus+, IT-based international diploma and professional
certificates in clinical toxicology (ITCT)(KA2 561915-EPP-1-2015-1-EG-EPPKA2-CBHE-JP)(2015-
- Workpackage leader Partner, LLP Erasmus Network, Science for Prevention Academic Network
(SPAN) (2013-2015)
- Partner, Leonardo Da Vinci LLP EU project on disability education (2009-2012)
- Chair, Dissemination board EU funded FP6 project EPICURE: Functional Genomics and
Neurobiology of Epilepsy: A Basis for New Therapeutic Strategies (LSH-037315). (2004-2009)
- UNESCO grant on learning impairment in epilepsy;
- Co-coordinator Grundtvig project. Curricular Education for Professionals Allied to Medicine
(PAMs) in Epilepsy 2006-2011.
- Co-ordinator of a UNESCO funded project on Gender Gap in science and technology in Malta,
- Co-ordinator of an EU Youth Grant - Epilepsy Youth in Europe, 2003

- Epilepsy Ambassador, International League Against Epilepsy and International Bureau of
Epilepsy, 2019
- Elected Fellow of the British Pharmacological Society, 2017
- Pektur award, Commission for Persons with Disability, 2017
- Italo Maltese award to La Sapienza University Rome Italy, 2009
- Visiting fellow US Fulbright scholarship to the University of Minnesota, 2007
- Pektur award, Commission for Persons with Disability, 2001
- DAAD grant, Bethel Epilepsy Clinic, Germany, 1999